NCF2H compounds are seen widely in approved and experimental drugs, yet methods to install this moiety are limited. A direct N-(difluoromethyl)sulfonamidation protocol is presented, and enables the diversification of NCF2H compounds to benefit drug discovery. This photoredox-catalyzed strategy employs a novel pyridinium reagent with broad functional group tolerance and showcases the effective adaptation
NCF 2 H化合物广泛应用于已批准和实验药物中,但安装该部分的方法有限。提出了直接的N- (二
氟甲基)磺酰胺化方案,使 NCF 2 H 化合物多样化,有利于药物发现。这种光氧化还原催化策略采用了一种具有广泛官能团耐受性的新型
吡啶鎓试剂,并展示了连续流方案的有效适应。